NQWM
AZN icon

Northwest Quadrant Wealth Management’s AstraZeneca AZN Stock Holding History

Northwest Quadrant Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Sell
1,362
-1
-0.1% -$193 0.06% 53
2025
Q4 		$251K Hold
1,363
– – 0.05% 60
2025
Q3 		$209K Buy
+1,363
New +$206K 0.04% 72
2025
Q2 		– Sell
-1,856
Closed -$273K – 71
2025
Q1 		$273K Buy
1,856
+16
+0.9% +$2.31K 0.06% 49
2024
Q4 		$241K Sell
1,840
-1
-0.1% -$140 0.05% 63
2024
Q3 		$287K Buy
1,841
+4
+0.2% +$646 0.07% 49
2024
Q2 		$286K Hold
1,837
– – 0.07% 47
2024
Q1 		$249K Sell
1,837
-248
-12% -$32.8K 0.06% 53
2023
Q4 		$281K Hold
2,085
– – 0.07% 48
2023
Q3 		$282K Buy
2,085
+7
+0.3% +$956 0.08% 41
2023
Q2 		$297K Sell
2,078
-12
-0.6% -$1.77K 0.08% 42
2023
Q1 		$290K Buy
2,090
+25
+1% +$3.36K 0.08% 43
2022
Q4 		$280K Hold
2,065
– – 0.09% 47
2022
Q3 		$226K Buy
2,065
+7
+0.3% +$888 0.07% 50
2022
Q2 		$270K Hold
2,058
– – 0.08% 48
2022
Q1 		$274K Buy
2,058
+14
+0.7% +$1.68K 0.08% 50
2021
Q4 		$238K Hold
2,044
– – 0.06% 57
2021
Q3 		$244K Sell
2,044
-115
-5% -$13.4K 0.07% 55
2021
Q2 		$260K Hold
2,159
– – 0.07% 52
2021
Q1 		$215K Buy
2,159
+18
+0.8% +$1.81K 0.07% 60
2020
Q4 		$215K Hold
2,141
– – 0.07% 56
2020
Q3 		$236K Buy
2,141
+9
+0.4% +$1K 0.09% 51
2020
Q2 		$226K Hold
2,132
– – 0.1% 48
2020
Q1 		$225K Buy
2,132
+21
+1% +$1.98K 0.1% 48
2019
Q4 		$211K Buy
+2,111
New +$199K 0.09% 65

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Northwest Quadrant Wealth Management's AZN Position: Q1 2026 in Review

Northwest Quadrant Wealth Management reduced its AstraZeneca (AZN) stake by 0.07% in Q1 2026, selling an estimated $193 and leaving 1,362 shares worth $269K. The position accounts for 0.06% of the portfolio, ranked #53.

Northwest Quadrant Wealth Management first reported a position in AZN in Q4 2019 and has held it in 25 quarters since. The position peaked at $297K in Q2 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Northwest Quadrant Wealth Management held 1,362 shares of AstraZeneca worth $269K as of Q1 2026.
  • Northwest Quadrant Wealth Management sold 1 AstraZeneca share in Q1 2026, an estimated $193.
  • AstraZeneca made up 0.06% of Northwest Quadrant Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Northwest Quadrant Wealth Management first reported a position in AstraZeneca in Q4 2019 and has held it in 25 quarters since.
  • Northwest Quadrant Wealth Management's AstraZeneca position peaked at $297K in Q2 2023.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Northwest Quadrant Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.